[1] I. Marmol, C. Sanchez-de-Diego, A. Pradilla Dieste, E. Cerrada, M.J. Rodriguez Yoldi, Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer, International journal of molecular sciences 18(1) (2017).
[2] M. Zamani, S.V. Hosseini, P. Mokarram, Epigenetic biomarkers in colorectal cancer: premises and prospects, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 23(2) (2018) 105-114.
[3] D.A. Goldstein, S.B. Zeichner, C.M. Bartnik, E. Neustadter, C.R. Flowers, Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies, Clinical colorectal cancer 15(1) (2016) 1-6.
[4] J. Jarroux, A. Morillon, M. Pinskaya, History, Discovery, and Classification of lncRNAs, Advances in experimental medicine and biology 1008 (2017) 1-46.
[5] F. Kopp, J.T. Mendell, Functional Classification and Experimental Dissection of Long Noncoding RNAs, Cell 172(3) (2018) 393-407.
[6] Y. Luo, J.J. Chen, Q. Lv, J. Qin, Y.Z. Huang, M.H. Yu, M. Zhong, Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway, Cancer letters 440-441 (2019) 11-22.
[7] M.H. Yang, L. Zhao, L. Wang, W. Ou-Yang, S.S. Hu, W.L. Li, M.L. Ai, Y.Q. Wang, Y. Han, T.T. Li, Y.Q. Ding, S. Wang, Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin beta3 transcriptional activating and MAPK/AKT signalling, Molecular cancer 18(1) (2019) 31.
[8] Y.Q. Wang, D.M. Jiang, S.S. Hu, L. Zhao, L. Wang, M.H. Yang, M.L. Ai, H.J. Jiang, Y. Han, Y.Q. Ding, S. Wang, SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial-Mesenchymal Transition, Cancer research 79(14) (2019) 3542-3556.
[9] G. Qi, L.L.J.R.a. num, eacute, ro, Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway, 126 (2020) 110100.
[10] Y. Chen, H. Gao, Y.L.J. Molecular, C. Endocrinology, Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway, 500 (2019) 110634.
[11] Y. Wu, N. Hao, S. Wang, X. Yang, B.L.J.J.o. Oncology, Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival, 2020 (2020) 1-8.
[12] X. Lan, X.J.J.o.C. Liu, M. Medicine, LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR‐145a‐5p on the down‐regulation of NUAK1 in nasopharyngeal carcinoma cell, 23(4) (2019).
[13] L. Bing, Z. Ming-nan, L. Li-feng, Z. Bin, Q.J.J.P.o.A. ences, lncRNA PVT1 regulates autophagy via increasing ATG7 expression in ovarian cancer cells, (2019).
[14] X. Peng, Y. Zhang, J. Gao, C.C.J. Experimental, M. Pathology, MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway, 114 (2020) 104368.
[15] Y. Song, Q. Guo, S. Gao, K.H.J. Biochemical, B.R. Communications, miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3, 516(3) (2019) 872-879.
[16] L. Yilin, C. Zhihua, L. Suyong, Z. Yan, L. Yisu, G. Ji, C.S.J.A.B.e.B. Sinica, MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1, (6) (2019) 6.
[17] Z. Yiping, L. Kai, Y. Liang, H. Yang, W. Lu, S.L.J.A.B.e.B. Sinica, miR-223-3p promotes cell proliferation and invasion by targeting Arid1a in gastric cancer, (2) (2020) 2.
[18] L. Yang, L. Liu, X. Zhang, Y. Zhu, C.R.J.P.-. Research, Practice, miR-96 enhances the proliferation of cervical cancer cells by targeting FOXO1, 216(4) (2020) 152854.
[19] R. Chen, L.J.A.-C.D. Zhang, MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer, (2019).
[20] Longchang, Huang, Ye, Zhang, Zengyao, Li, Xiaoqian, Zhao, Zhong, X.J.U.E.G. Journal, MiR-4319 suppresses colorectal cancer progression by targeting ABTB1, (2019).
[21] D. Tang, Z. Yang, F. Long, L. Luo, B. Yang, R. Zhu, X. Sang, G. Cao, K. Wang, Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis, Journal of cellular physiology 234(11) (2019) 20816-20828.
[22] H. Wu, Q. Zou, H. He, Y. Liang, M. Lei, Q. Zhou, D. Fan, L. Shen, Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling, Cancer medicine 8(5) (2019) 2484-2495.
[23] S. Pan, Y. Liu, Q. Liu, Y. Xiao, B. Liu, X. Ren, X. Qi, H. Zhou, C. Zeng, L. Jia, HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway, Biochimica et biophysica acta. Molecular cell research 1866(5) (2019) 750-760.
[24] L. Wang, Z. Chen, L. An, Y. Wang, Z. Zhang, Y. Guo, C. Liu, Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 38(6) (2016) 2389-400.
[25] Z. Liu, Z. Kang, Y. Dai, H. Zheng, Y. Wang, Long noncoding RNA LINC00342 promotes growth of infantile hemangioma by sponging miR-3619-5p from HDGF, American journal of physiology. Heart and circulatory physiology 317(4) (2019) H830-H839.
[26] H. Tang, L. Zhao, M. Li, T. Li, Y. Hao, Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer, Journal of cellular biochemistry 120(4) (2019) 5055-5061.
[27] Q.F. Chen, J.L. Kong, S.C. Zou, H. Gao, F. Wang, S.M. Qin, W. Wang, LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p, European review for medical and pharmacological sciences 23(17) (2019) 7408-7418.
[28] J. Xu, R. Zhang, J. Zhao, The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 41(2) (2017) 635-644.
[29] C. Li, F. Tan, Q. Pei, Z. Zhou, Y. Zhou, L. Zhang, D. Wang, H. Pei, Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis, Cell proliferation 52(4) (2019) e12632.
[30] L. Shi, X. Hong, L. Ba, X. He, Y. Xiong, Q. Ding, S. Yang, G. Peng, Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression, Cell death & disease 10(3) (2019) 150.
[31] X.M. Jiang, X.N. Yu, T.T. Liu, H.R. Zhu, X. Shi, E. Bilegsaikhan, H.Y. Guo, G.Q. Song, S.Q. Weng, X.X. Huang, L. Dong, H.L.A. Janssen, X.Z. Shen, J.M. Zhu, microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 105 (2018) 1147-1154.
[32] B. Zhang, Y. Liu, J. Zhang, Silencing of miR-19a-3p enhances osteosarcoma cells chemosensitivity by elevating the expression of tumor suppressor PTEN, Oncology letters 17(1) (2019) 414-421.
[33] M. Chen, M. Lin, X. Wang, Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression, Oncology reports 39(2) (2018) 619-626.
[34] M. Ouchida, H. Kanzaki, S. Ito, H. Hanafusa, Y. Jitsumori, S. Tamaru, K. Shimizu, Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach, PloS one 7(8) (2012) e44095.